Lidocaine HCL Injection, USP 2% 200mg/10mL (20mg/mL) and EPINEPHRINE HCl 1:200,000, 10 ml Single Dose Vial, Rx only, Compounded drug by Medivant Healthcare, 158 S Kyrene Rd, Chandler, AZ 85226, NDC 81483-0038-0, UPC 3 81483 00380 2
Published July 17, 2024 · Recall initiated: July 3, 2024
Summary
FDA records drug Class II recall D-0594-2024, published July 17, 2024 and initiated July 3, 2024. Recalling firm: TAILSTORM HEALTH INC; Status: Ongoing; Reported quantity: 12,525 10 mL vials; Lot: Lot Number: 2311003, Expiration Date: 11/13/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug: reduced efficacy for epinephrine
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- TAILSTORM HEALTH INC
- Distributor
- Nationwide in the USA
- Lot
- Lot Number: 2311003, Expiration Date: 11/13/2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAVerapamil Hydrochloride Injection, USP 10 mg/4 mL (2.5 mg/mL), 5 x 4 mL Single-Dose Vial per carton, Rx Only,July 17, 2024
- FDAMicafungin for injection, USP, 100 mg/vial, Single-Dose Vial, Rx Only, Manufactured by: Zydus LifesciencesJuly 17, 2024
- FDAVerapamil Hydrochloride Injection, USP 5 mg / 2mL(2.5 mg/mL), packaged as (a) 25x2 mL Single-Dose Vial perJuly 17, 2024
- FDAMicafungin for injection, USP, 100 mg/vial, Single-Dose Vial, Rx Only, Manufactured for: Northstar Rx LLC,July 17, 2024
- FDABlemfree All Day Lotion (salicylic acid 0.5% w/w), packaged in a) 1 oz. 29 ML tube NDC:53228-003-01 b) 4 OZJuly 17, 2024
- FDADiflorasone Diacetate Ointment, USP, 0.05%, 60g tube, Rx only, Mfd. By: Lyne Laboratories, Inc., Brockton, MAJuly 17, 2024
Questions about this recall
Was Lidocaine HCL Injection, USP 2% 200mg/10mL (20mg/mL) and EPINEPHRINE HCl 1:200,000, 10 ml Single Dose Vial, Rx only, Compounded drug by Medivant Healthcare, 158 S Kyrene Rd, Chandler, AZ 85226, NDC 81483-0038-0, UPC 3 81483 00380 2 recalled?
Yes. FDA published recall D-0594-2024 on July 17, 2024. Reported hazard: Subpotent Drug: reduced efficacy for epinephrine
What should I do if I have this product?
Voluntary: Firm initiated · Letter